Stichting Hemato-oncologie Voor Volwassenen Nederland

This study is testing whether a combination of two targeted drugs, venetoclax and acalabrutinib, can help control chronic lymphocytic leukemia (CLL) in patients whose cancer has returned after their first round of treatment. The trial will enroll 60 adults who previously received…

This study aims to prevent heart damage in patients receiving chemotherapy for a common type of lymphoma. Researchers are testing whether giving a drug called dexrazoxane before each chemotherapy session can protect the heart muscle. The trial will involve 324 adults with diffuse…